Nevertheless, prior research demonstrated that ADRA2C is involved in the tumorigenesis of diverse cancer types, such as breast cancer 10 and colorectal cancer 11, suggesting that ADRA2C may be a novel biomarker for the diagnosis or treatment of cancer. The gene discussed is ADRA2C; the disease is colorectal cancer.